Literature DB >> 7699583

From piecewise to full physiologic pharmacokinetic modeling: applied to thiopental disposition in the rat.

W F Ebling1, D R Wada, D R Stanski.   

Abstract

Physiologically based pharmacokinetic modeling procedures employ anatomical tissue weight, blood flow, and steady tissue/blood partition data, often obtained from different sources, to construct a system of differential equations that predict blood and tissue concentrations. Because the system of equations and the number of variables optimized is considerable, physiologic modeling frequently remains a simulation activity where fits to the data are adjusted by eye rather than with a computer-driven optimization algorithm. We propose a new approach to physiological modeling in which we characterize drug disposition in each tissue separately using constrained numerical deconvolution. This technique takes advantage of the fact that the drug concentration time course, CT(t), in a given tissue can be described as the convolution of an input function with the unit disposition function (UDFT) of the drug in the tissue, (i.e., CT(t) = (Ca(t)QT)*UDFT(t) where Ca(t) is the arterial concentration, Q tau is the tissue blood flow and * is the convolution operator). The obtained tissue until disposition function (UDF) for each tissue describes the theoretical disposition of a unit amount of drug infected into the tissue in the absence of recirculation. From the UDF, a parametric model for the intratissue disposition of each tissue can be postulated. Using as input the product of arterial concentration and blood flow, this submodel is fit separately utilizing standard nonlinear regression programs. In a separate step, the entire body is characterized by reassembly of the individuals submodels. Unlike classical physiologic modeling the fit for a given tissue is not dependent on the estimates obtained for other tissues in the model. Additionally, because this method permits examination of individual UDFs, appropriate submodel selection is driven by relevant information. This paper reports our experience with a piecewise modeling approach for thiopental disposition in the rat.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7699583     DOI: 10.1007/bf02353622

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  21 in total

1.  Distribution of blood (Fe 59) and plasma (I 131) volumes of rats determined by liquid nitrogen freezing.

Authors:  N B EVERETT; B SIMMONS; E P LASHER
Journal:  Circ Res       Date:  1956-07       Impact factor: 17.367

2.  Tissue weights of the rat. I. Normal values determined by dissection and chemical methods.

Authors:  W O CASTER; J PONCELET; A B SIMON; W D ARMSTRONG
Journal:  Proc Soc Exp Biol Med       Date:  1956-01

Review 3.  Regional pharmacokinetics. I. Physiological and physicochemical basis.

Authors:  R N Upton
Journal:  Biopharm Drug Dispos       Date:  1990-11       Impact factor: 1.627

4.  Blood flow measurements with radionuclide-labeled particles.

Authors:  M A Heymann; B D Payne; J I Hoffman; A M Rudolph
Journal:  Prog Cardiovasc Dis       Date:  1977 Jul-Aug       Impact factor: 8.194

5.  Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited.

Authors:  D R Stanski; P O Maitre
Journal:  Anesthesiology       Date:  1990-03       Impact factor: 7.892

Review 6.  An inequality-constrained least-squares deconvolution method.

Authors:  D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

7.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

8.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

9.  Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat.

Authors:  Y Igari; Y Sugiyama; S Awazu; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

10.  MIC-II - a program for the determination of cardiac output, arterio-venous shunt and regional blood flow using the radioactive microsphere method.

Authors:  R Schosser; K E Arfors; K Messmer
Journal:  Comput Programs Biomed       Date:  1979-01
View more
  24 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Susan Murby; Sophie Gisbert; Brent Collins; Kelly Dickens; Judith Duffy; Ziad Hussain; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

3.  A physiologically-based pharmacokinetic model of drug detoxification by nanoparticles.

Authors:  Marissa S Fallon; Manoj Varshney; Donn M Dennis; Anuj Chauhan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-10       Impact factor: 2.745

4.  Lumping of whole-body physiologically based pharmacokinetic models.

Authors:  I A Nestorov; L J Aarons; P A Arundel; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

5.  A recirculatory model of the pulmonary uptake and pharmacokinetics of lidocaine based on analysis of arterial and mixed venous data from dogs.

Authors:  T C Krejcie; M J Avram; W B Gentry; C U Niemann; M P Janowski; T K Henthorn
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

6.  Commentary on "Physiologically based pharmacokinetic modeling as a tool for drug development".

Authors:  T M Ludden; W R Gillespie; W J Bachman
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

7.  Physiologically based pharmacokinetics of cyclosporine A: reevaluation of dose-nonlinear kinetics in rats.

Authors:  C Tanaka; R Kawai; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

8.  Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.

Authors:  Sven Björkman
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-08       Impact factor: 2.745

9.  In vivo relationships between the cerebral pharmacokinetics and pharmacodynamics of thiopentone in sheep after short-term administration.

Authors:  R N Upton; G L Ludbrook; C Grant; E C Gray
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

10.  Quantitative relationship between the octanol/water partition coefficient and the diffusion limitation of the exchange between adipose and blood.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2010-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.